Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lung Capacity01:47

Lung Capacity

56.4K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.4K
Appendicitis-II: Diagnostic Studies and Management01:29

Appendicitis-II: Diagnostic Studies and Management

581
Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
581
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

2.6K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.6K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

3.2K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Improving Translational Accuracy02:07

Improving Translational Accuracy

3.7K
3.7K
Improving Translational Accuracy02:07

Improving Translational Accuracy

15.0K
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
15.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Theoretical Clinical Utility of Advanced Practice Provider Use of an Artificial Intelligence Radiomics-based Tool for Pulmonary Nodule Evaluation and Management.

CHEST pulmonary·2026
Same author

Lung Cancer Yield by Baseline Screening Lung CT Screening Reporting and Data System (Lung-RADS) Assignment and Patient Factors: The Population-Based Research to Optimize the Screening Process Lung Consortium.

CHEST pulmonary·2026
Same author

Reframing computed tomography-associated cancer concerns in lifesaving screening: keeping the focus on lives saved.

Lancet regional health. Americas·2026
Same author

Clinicians' cancer risk assessment among patients with pulmonary nodules: a qualitative study.

Annals of the American Thoracic Society·2026
Same author

Impact of the Social Vulnerability Index on Pulmonary Embolism Mortality.

CHEST pulmonary·2026
Same author

Examining trends in lung cancer screening over 10 years: Eligibility, participation, cancer detection, and quality implications.

Cancer·2025
Same journal

Nonsteroid treatment options in (pulmonary) sarcoidosis. When to consider and why?

Current opinion in pulmonary medicine·2026
Same journal

Multidisciplinary approach in cardiac sarcoidosis: to biopsy or not?

Current opinion in pulmonary medicine·2026
Same journal

Low diffusion capacity in pulmonary hypertension.

Current opinion in pulmonary medicine·2026
Same journal

Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence.

Current opinion in pulmonary medicine·2026
Same journal

Oxygen therapy in interstitial lung disease - navigating benefit and burden.

Current opinion in pulmonary medicine·2026
Same journal

Preclinical and clinical advances in pulmonary hypertension associated with systemic sclerosis.

Current opinion in pulmonary medicine·2026
See all related articles

Related Experiment Video

Updated: Feb 7, 2026

Using Computer-based Image Analysis to Improve Quantification of Lung Metastasis in the 4T1 Breast Cancer Model
08:32

Using Computer-based Image Analysis to Improve Quantification of Lung Metastasis in the 4T1 Breast Cancer Model

Published on: October 2, 2020

7.0K

Improving lung cancer screening diagnostic efficiency.

Christopher R Caruso1,2, Roger Y Kim1,2

  • 1Division of Pulmonary, Allergy, and Critical Care, Department of Medicine.

Current Opinion in Pulmonary Medicine
|February 6, 2026
PubMed
Summary
This summary is machine-generated.

Improving lung cancer screening (LCS) involves enhancing diagnostic efficiency by focusing on early detection and reducing errors. Efforts target screening eligibility, adherence, and evaluating concerning findings to balance sensitivity and specificity.

Keywords:
diagnostic efficiencyhealth services researchlung cancer screeningquality

More Related Videos

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

16.2K
Combined Supine and Standing Imaging for Varicocele: An Improved Diagnostic Approach
04:15

Combined Supine and Standing Imaging for Varicocele: An Improved Diagnostic Approach

Published on: November 22, 2024

728

Related Experiment Videos

Last Updated: Feb 7, 2026

Using Computer-based Image Analysis to Improve Quantification of Lung Metastasis in the 4T1 Breast Cancer Model
08:32

Using Computer-based Image Analysis to Improve Quantification of Lung Metastasis in the 4T1 Breast Cancer Model

Published on: October 2, 2020

7.0K
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

16.2K
Combined Supine and Standing Imaging for Varicocele: An Improved Diagnostic Approach
04:15

Combined Supine and Standing Imaging for Varicocele: An Improved Diagnostic Approach

Published on: November 22, 2024

728

Area of Science:

  • Pulmonary Medicine
  • Oncology
  • Radiology

Background:

  • Lung cancer screening (LCS) aims for early detection but faces challenges in diagnostic efficiency.
  • Improving LCS requires addressing both accurate diagnosis and minimizing unnecessary procedures.

Purpose of the Study:

  • To explore strategies for enhancing the diagnostic efficiency of lung cancer screening.
  • To balance the need for early lung cancer detection with the reduction of diagnostic errors.

Main Methods:

  • Review of recent advancements and ongoing debates in LCS.
  • Analysis of key areas: eligibility, uptake, adherence, and diagnostic evaluation of findings.

Main Results:

  • LCS diagnostic efficiency improvements target eligibility, adherence, and evaluation of concerning findings.
  • Suboptimal uptake and adherence remain concerns, impacting early-stage lung cancer detection.
  • Optimizing the diagnostic pathway is crucial to reduce invasive testing for benign lesions and overdiagnosis.

Conclusions:

  • Enhancing LCS diagnostic efficiency necessitates balancing sensitivity for early-stage lung cancer detection.
  • Minimizing false negatives (missed diagnoses) and false positives (unnecessary procedures) is critical.
  • Strategies include improving nodule risk assessment and reducing non-malignant resection rates.